Lifeward to Report Third Quarter Financial Results on November 14, 2025
Rhea-AI Summary
Lifeward (NASDAQ: LFWD) will release its third quarter 2025 financial results before markets open on Friday, November 14, 2025. A conference call and live webcast with CEO Mark Grant and CFO Almog Adar is scheduled for 8:30 a.m. EST the same day to discuss results.
Analysts and investors can join via toll-free U.S. dial-in 1-833-316-0561, international dial-in 1-412-317-0690, or regional numbers including Germany and Israel; participants should reference the "Lifeward Earnings Call" access code. The live webcast is available on the company website GoLifeward.com in Investors or at https://edge.media-server.com/mmc/p/522gfyx4, with an archived replay to follow on the site.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, LFWD gained 4.08%, reflecting a moderate positive market reaction. Argus tracked a trough of -8.6% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $329K to the company's valuation, bringing the market cap to $8M at that time.
Data tracked by StockTitan Argus on the day of publication.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its third quarter 2025 financial results before the markets open on Friday, November 14, 2025.
Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following:
| Toll free (U.S.) | 1-833-316-0561 |
| International (U.S) | 1-412-317-0690 |
| Germany | 0800-6647650 |
| Israel | 1-80-9212373 |
| Access Code | Please reference the “Lifeward Earnings Call” |
The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/522gfyx4. An archived webcast will also be available on the company's website.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Lifeward Media Relations:
Almog Adar
Chief Financial Officer
Lifeward Ltd.
E: media@golifeward.com
Lifeward Investor Contact:
Almog Adar
Chief Financial Officer
Lifeward Ltd.
E: ir@golifeward.com